Pharmaceutic Pharmacokinetics Pharmacodynamics ...for parenteral drugs Pharmacokinetics Pharmacodynamics I. Pharmaceutic Phase (drug dissolution) disintegration. breakdown of a tablet into smaller particles dissolution. dissolving of the smaller particles in the GI fluid before absorption - rate of dissolution. the time it takes the drug to disintegrate and to dissolve - excipients (fillers & inert substances). allow the drug to take on a particular size and shape and to enhance drug dissolution - drugs in acidic fluids with a pH of 1 or 2 are disintegrated and absorbed faster rather than in alkaline fluids - alkaline drugs would become ionized and have difficulty crossing cell membrane barriers - very young and older adults have less gastric acidity - enteric-coated drugs resist disintegration in the gastric acid of the stomach, until the drug reaches the alkaline environment of the small intestine - enteric-coated tablets or capsules and sustained-release (beaded) capsules should not be crushed ; crushing would alter the place and time of absorption of the drug - food in the GI tract may interfere with the dissolution of certain drugs, however, it serves as a protectants necessary to dilute the drug concentration, avoiding irritation in the gastric mucosa II. Pharmacokinetic Phase (drug action). study of how medications enter the body, reach their site of action, metabolize, and exit the body a. absorption. process by which a drug passes into the bloodstream i. factors affecting drug absorption 1. route of administration correct form of the drug must be given by the route intended some drugs are absorbed by tissues before they reach the stomach (nitroglycerin administered sublingually) ; however, if swallowed, the drug will undergo on a first-pass effect (hepatic first pass) by the liver, where it will be destroyed. This requires higher oral doses in order to achieve the appropriate effect IV ministration is the route of choice for rapid action rectum ministration is used only when other routes are unavailable or when the intended action is localized to the rectum or sigmoid colon skin medications have slow absorption medications placed on mucous membranes and respiratory airways are quickly absorbed oral medications have slow overall rate of absorption, and absorbed mainly in small intestine through the action of the extensive mucosal villi ; reduced villi equates decreased absorption 2. ability of the medication to dissolve body absorbs liquid solutions and suspensions more readily than tablets or capsules some drugs intended to be absorbed slowly are suspended in low- solubility medium (oil) medications that are basic are not absorbed before reaching the small intestine acid medium in the stomach which vary according to the time of the day, foods ingested, use of antacid medications, and the age of the client protein-based drugs such as insulin and growth hormones are destroyed in the small intestine by digestive enzymes 3. blood flow to the site of administration application of heat increases blood flow to the area, thus absorption is accelerated injection of an epinephrine (vasoconstrictor) can slow absorption of other drugs poor circulation to the stomach as a result of shock, vasoconstrictor drugs, or disease hampers absorption exercise can decrease blood flow by causing more blood to flow to the peripheral muscle, thereby decreasing blood circulation to the GI tract 4. body surface area when a medication comes in contact with a large surface area, the medication is absorbed at a faster rate majority of medications are absorbed in the small intestine rather than the stomach 5. lipid solubility of a medication GI membrane is composed mostly of lipid and protein, so drugs that are lipid soluble pass rapidly ' large particles pass through the cell membrane if they are nonionized highly-lipid soluble medications easily cross the cell membrane and are absorbed quickly foods can delay the dissolution of some drugs as well as their passage into the small intestine ; food can also combine with molecules of certain drugs, thereby preventing their absorption through the change in molecular structure that have occurred pain, stress, and foods that are solid, hot, or high in fat can slow gastric emptying time, so the drug remains in the stomach longer calcium carbonate and many of the antifungals need an acidic environment to achieve greater drug absorption, thus food can stimulate the production of gastric acid drugs that are lipid-soluble and nonionized are absorbed faster that water-soluble and ionized drugs 6. ability of the drug to enter the membrane water-soluble drugs need a carrier, either enzyme or protein, to pass through the membrane weak acid drugs (aspirin) are less ionized in stomach, passing the lining of the stomach easily and rapidly an infant's gastric secretions have a higher pH (alkaline) than those of adults, thus infants can absorb more penicillin ii. processes 1. passive occurs mostly by diffusion (movement from higher conc. To lower conc.) ; drug doesn't require energy 2. active requires a carrier such as an enzyme or protein to move the drug against a concentration gradient ; energy is required 3. pinocytosis a process by which cells carry a drug across their membrane by engulfing the drug particles iii. bioavailabity. the percentage of the administered drug dose that reaches the systemic circulation ; for the oral route of drug administration, bioavailability occurs after absorption and first-pass metabolism ; the percentage of bioavailability for the oral route is always less than 100%, but for the IV route it is 100% 1. factors that alter bioavailability the drug form route of administration GI mucosa and motility food and other drugs changes in liver metabolism caused by liver dysfunction or inadequate hepatic blood flow b. distribution. transportation of a drug from its site of absorption to its site of action ; process by which the drug becomes available to body fluids and body tissues i. factors affecting drug distribution 1. circulation how fast it reaches the site depends on the vascularity of the various tissues and organs conditions that limit blood flow or blood perfusion (congestive heart failure) inhibit the distribution of a medication 2. membrane permeability medication has to pass through all of the organ's tissues and biological membranes blood-brain barrier allows only fat-soluble medications ; cns infections often require treatment with antibiotics injected directly into the subarachnoid space in the spinal cord placental membrane also has a non-selective barriers to medications 3. protein binding the degree to which medications bind to serum proteins such as albumin affects medication distribution unbound or "free" medication is the active form of the medication drugs bound to proteins cannot leave the systemic circulation to get to the site of action when two highly protein-bound drugs are given concurrently, and when a low serum protein level decreases (older adults experiencing from hypoalbuminemia and patients with liver or kidney disease and malnourished) the number of protein-binding sites and can cause an increase in the amount of free drug in the plasma, drug toxicity may then result... a decreased drug dose is needed as there is not as much protein circulated for the drug to bind to clients who are old, who have liver disease and malnutrition have a decrease in albumin in the bloodstream. consequently, they are at risk for an increase in medication activity and/or toxicity most anticonvulsants bind primarily to albumin ; some basic drugs such as antidysrhythmics (e.g., lidocaine, quinidine) bind mostly to globulins ii. volume of drug distribution (Vd) is dependent on drug dose and its concentration in the body ; drugs with a larger volume of drug distribution have a longer half-life and stay in the body longer iii. nurse's additional responsibilities in administering medications 1. checking the protein-binding percentage of all drugs 2. check the patient’s plasma protein and albumin levels, because a decrease in plasma protein (albumin) decreases protein-binding sites 3. check for abscesses, exudates, body glands, and tumors for it may hinder drug distribution ; antibiotics do not distribute well at abscess and exudate sites 4. check which drugs may cross into breast milk before administering to a lactating patient c. metabolism (biotransformation). how the body chemically modifies the drug d. excretion (elimination). how the body gets rid of the drug. III. Pharmacodynamics. study of the effects of drugs in the
American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists American Society of Anesthesiologists (ASA)